Cdk5 hyperactivation contributes to several neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD; Cheung and Ip, 2012). Here, CDK5 is linked to early-onset autosomal dominant Alzheimer disease.